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Abstract: It is not clear whether Helicobacter pylori (Hp) infection affects insulin levels and insulin sensitivity. We aimed to determine
insulin sensitivity and beta cell function, and to evaluate serum lipids in subjects with and without Hp infection. Eighty non-obese
young adult males, 40 of whom were Hp positive and 40 were negative, were included in the study. Two endoscopic biopsy
specimens were obtained from each subject. Height, weight and waist-hip circumference were measured, and body mass index (BMI)
was calculated. Serum glucose, total, HDL, LDL and VLDL-cholesterol and triglyceride levels were determined. Body fat mass and
percentage were determined by bioelectric impedance. Serum insulin levels were measured by the RIA method. HOMA was used as
an index of pancreatic beta cell function and insulin sensitivity. The independent-t test was used in the comparison of results. Age,
BMI, waist and hip circumferences, and fat percentages did not exhibit any statistical differences. Mean HOMA-B [111.7, in Hp(+)
and 112.0 in Hp(-) subjects] and HOMA-S [67.7 in Hp(+) and 60.7 Hp(-) subjects] did not differ amoung the groups. The lipid and
aminotransferase levels of the 2 groups were also similar.
Conclusion: Hp infection is not associated with impairment of insulin sensitivity and deterioration of the glucose metabolism. It seems
to be metabolically neutral in terms of serum lipids and aminotransferase levels.
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Introduction
In patients with diabetes mellitus, chronic infections
are frequent and severe, due to the impairment of their
immune status. However, data on the prevalence of
Helicobacter pylori (Hp) infection in diabetics are scanty
and contradictory (1). Due to the fact that diabetes
mellitus may be associated with a variety of upper
gastrointestinal tract complaints, investigators sought to
determine whether Hp infection is linked to different
forms of diabetes (2). The relationship between diabetes
and Hp infection is still controversial. Some authors have
claimed that there is no association between Hp infection,
glycemic status, and duration of diabetes and upper
gastrointestinal symptoms in diabetic subjects (1-4). On
the other hand some authors have pointed out that a
higher prevalence of Hp infection was seen in diabetic
patients with dyspepsia. The Hp infection was also found

to be significantly associated with the presence of
endoscopic lesions and chronic gastritis in diabetic
patients, but not in the controls (5). Alterations in the
glucose metabolism in diabetes have been suggested as
promoting Hp colonization, but the probable relationship
between Hp and insulin resistance has not been carefully
investigated. Although some studies showed no
association between Hp status and levels of total
cholesterol, triglyceride, or glucose (6-8), the data in the
literature have not clarified whether Hp affects insulin
plasma levels and therefore insulin sensitivity. Peach and
Barnett (9) showed that women infected with Hp had a
lower mean fasting plasma glucose concentration than did
non-infected women. The aims of this study are to
determine insulin sensitivity and beta cell function, and to
evaluate serum lipids in subjects with and without Hp
infection.
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Materials and Methods
Subjects: Eighty non-obese young adult males, 40 of
whom were Hp positive and 40 negative (aged 20-45 )
who complained of dyspeptic problems were included in
the study. Subjects were selected from patients admitted
to the endoscopy unit for 6 months. Exclusion criteria
were: Men younger than 20 and older than 45, female
gender, obesity (BMI > 25 kg/m2), diabetes mellitus,
hypertension and coronary heart disease. Individuals
using drugs that affect insulin sensitivity were also
excluded from the study.
Methods: The patients’ heights, weights, waist and
hip circumferences were measured, and body mass
indexes (BMI) were calculated. Weight was measured
without shoes and in light clothing, and was recorded to
the nearest 0.5 kg. Subjects were measured barefooted
and bareheaded, and were recorded to the nearest
centimeter. BMI was expressed as weight (kg) by height
(meters) squared. Waist circumference was taken as the
maximum abdominal girth and was recorded to the
nearest centimeter. Hip circumference was taken as the
maximum circumference at the level of the greater
trochanter and was also recorded to the nearest
centimeter. Endoscopic examination was performed by an
Olympus GIF XQ type 30 device in all subjects. Two
biopsies were taken from each patient using Olympus FB25K biopsy forceps: one from the greater curvature of
the mid-antrum, the other from the incisura angularis.
Each biopsy specimen was processed by urease test.
Group - 1 (patients, n = 40) consisted of subjects with
positive urease tests, and group - 2 (control, n = 40)
composed subjects with negative urease tests. Trained
hospital staff measured blood pressure. Informed and
written consent was obtained from all participants.
Biochemistry: Blood samples were obtained at 08:00
after a 12 hour fasting period, and were centrifuged and
separated immediately. After collection, serum samples
were stored at -80 0C until assayed. Serum glucose, total,
HDL and VLDL-cholesterol and triglyceride levels were
determined by the use of an Abbott Aeroset autoanalyzer.
LDL-cholesterol was calculated by Friedwald’s equation
(LDL chol = Total chol - (HDL + TG / 5). Serum insulin
levels were measured by the Radioimmunoassay method
(RIA, Diagnostic System Laboratories, Webster, Texas,
USA, Berthold LB 2111). The intra-assay coefficents of
variation (CVs) were 8.2%, 4.8% and 6.3%, at serum
concentrations of 4.75, 17.62 and 54.60 µU/ml,
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respectively. The interassay CVs were 11.2%, 7.5% and
4.7%, at serum concentrations of 4.92, 16.23, and
52.92 µU/ml, respectively. Body fat percentage and fat
mass were determined by bioelectric impedance (Body
composition analyzer, TANITA Corporation, Tokyo,
Japan).
Evaluation of beta cell function and tissue insulin
sensitivity: Since the measurement of insulin sensitivity
in vivo involves techniques that are not readily available to
most investigators and requires significant amounts of
both physician and patient time, Turner et all (10, 11)
developed a mathematical model that predicted insulin
sensitivity from simple measurement of fasting plasma
glucose and insulin concentrations. This approach was
called homeostasis model assessment (HOMA). If the
simultaneous fasting plasma glucose and insulin levels are
known, the model will generate estimates of the ß-cell
secretory capacity and insulin sensitivity required to
produce the measured glucose and insulin concentrations.
The euglycemic insulin clamp technique provides the most
direct measure of tissue sensitivity to insulin and has
become the gold standard for measuring insulin action in
vivo (12). Authors found that assessment of insulin by
HOMA sensitivity correlated well with that determined by
the euglycemic insulin clamp technique (r = 0.88, p <
0.0001) (10). In our study mathematical modelling of the
fasting glucose and insulin pairs HOMA was used as an
indexs of pancreatic beta cell function [HOMA-(%B)] and
tissue insulin sensitivity [HOMA-(%S)]. HOMA-(%S) and
HOMA-(%B) were determined by the use of HOMA and a
CIGMA – computer program application (Dr. Jonathan C
Lewy, Diabetes Research Laboratories, Radcliffe
Infirmary, Oxford, UK)
Statistical analysis: All results were given as mean ±
standard deviation. Results were stored and an
independent-t test was used in the comparison of results.

Results
The all metabolic and anthropometrical results of both
Hp(+) subjects and the healthy control group are shown
in the table. Ages, BMIs, waist and hip circumferences, fat
percentages and fat masses of the groups did not exhibit
any statistical differences. The mean HOMA-B(%) value
of subjects with Hp infection was 111.7 ± 38.5 and
112.0 ± 36.9 in the control group. On the other hand,
the mean HOMA-S(%) value was 67.7 ± 38.6 in Hp(+)
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Table. All anthropometrical and metabolic parameters of both groups (helicobacter (+) and (-)
subjects).
Group-1

Group-2

(Helicobacter pylori +)

(Helicobacter Pylori -)

Age (yr)

35.3 ± 8.6

35.7 ± 6.9

BMI (kg/m2)

24.7 ± 4.3

24.0 ± 3.8

Waist circ. (cm)

86.8 ± 12.6

89.1 ± 15.6

Hip circum. (cm)

102.1 ± 9.5

101.3 ± 9.4

Fat percent (%)

%20.5 ± 9.03

%21.0 ± 9.3

Fat mass (kg)

14.1 ± 6.2

15.4 ± 6.6

T.cholesterol (mg/dl)

180.3 ± 36.9

202.3 ± 38.0

Triglyceride (mg/dl)

120.0 ± 53.3

171.3 ± 125.7

LDL-chol (mg/dl)

108.6 ± 29.4

117.4 ± 37.2

HDL-chol (mg/dl)

41.8 ± 9.9

43.2 ± 8.9

VLDL-chol (mg/dl)

25.7 ± 20.2

29.7 ± 23.5

AST (mU/L)

22.3 ± 8.3

21.3 ± 6.1

ALT (mU/L)

26.0 ± 16.7

23.0 ± 12.7

ALP (mU/L)

85.6 ± 18.1

82.3 ± 26.0

Insulin /IU/ml)

8.1 ± 5.2

7.8 ± 3.3

Glucose(mmol/L)

4.93 ± 0.4

5.16 ± 0.6

HOMA-B(%)

111.7 ± 38.5

112.0 ± 36.9

HOMA-S(%)

67.7 ± 38.6

60.7 ± 34.1

subjects, and 60.7 ± 34.1 in control subjects. Not only
the HOMA-B values, but also the HOMA-S results in both
groups (Hp positive and negative) were similar. The lipid
profile (total cholesterol, LDL-cholesterol, VLDLcholesterol, HDL-cholesterol, triglyceride), and
transaminase (ALT and AST) levels in the 2 groups were
also similar.

Discussion
Little information about the prevalence of Hp infection
in diabetics is available in the literature (1). The best
evidence of an association between Hp infection and
diabetes comes from case control studies. There are,
however, inconsistencies among different studies. There
is no substantial evidence that Hp infection affects
diabetic control or insulin requirements. The data in the
literature have not clarified whether Hp affects insulin
plasma levels and therefore insulin sensitivity. We showed
that there is no relationship between insulin sensitivity
and Hp infection. Although some studies showed that
there is no association between Hp status and levels of

total cholesterol, triglyceride or glucose, we could not
find any data about Hp infection and insulin sensitivity.
Many factors affect glucose metabolism and insulin
sensitivity, such as obesity, gender and aging. Obesity
significantly affects insulin senstivity and beta cell
function. It leads to insulin resistance by a variety of
mechanisms, for example glucotoxicity, tumor necrosis
factor-alpha and resistin (13). The menstrual cycle also
affects insulin sensitivity, which is higher in the follicular
phase than the luteal phase (14). Knowledge of the
variations in insulin sensitivity that occur during the
normal menstrual cycle provides a basis for comparison
for studies of other clinical conditions. In addition, this
phenomenon should be considered if the determination of
insulin resistance is the purpose of particular
epidemiological studies (8). It has been suggested that
postmenopausal women taking oral estrogen or those
taking a combination of estrogen and HRT are more
insulin-resistant than women not on HRT, even when
women are of comparable total and abdominal adiposity
(15). It has been pointed out that glycemic control
deteriorates with age in healthy, non-diabetic individuals,
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and age related rises in fasting plasma glucose result from
a small but steady decline in pancreatic beta cell function
(16). Aging is also associated with an increased incidence
of hypertension, macrovascular disease and type 2
diabetes. The elderly are more glucose intolerant and
insulin resistant. However, insulin secretion appears to
decrease with age even after adjustments for differences
in adiposity, fat distribution and physical activity. The
glucose intolerance of aging may be due, in part, to
decreased insulin sensitivity of pancreatic cells to
insulinotropic gut hormones (GLP1/GIP) and in part to
alterations in hepatic glucose production (17). In addition
it has been reported that glycemia and insulinemia
increase with age and that a small deterioration occurs in
insulin sensitivity with age in animals (18). In order to
eliminate the effects of aging, obesity, gender, menstrual
cycle and HRT on glucose metabolism and insulin
sensitivity, we carried out this study only in non-obese
young adult males aged between 20 and 45. Peach and
Barnett (9) showed that women infected with Hp had a
lower mean fasting plasma glucose concentration than did
non-infected women. However our study does not
support this finding. We do not think that there is any
association between Hp positivity and insulin sensitivity /
glucose metabolism.

infection and/or gastrointestinal complaints. Therefore
the subjects included in the study form a homogeneous
group in terms of gender, age, body weight, waist
circumference, fat percentage and fat mass. We therefore
suggest that Hp infection does not lead to deterioration
in lipid metabolism and serum transaminases in addition
to insulin sensitivity and glucose metabolism in
homogeneous groups from the point of view of gender,
body weight and age. Scragg et al. (6) studied a large
group of asymptomatic, non-diabetic workers in New
Zealand and found no association between Hp infection
and total cholesterol, triglyceride, or glucose. It was also
shown that there was no association between Hp status
and hypercholesterolemia and/or diabetes in other studies
(2,7,8).
We concluded that : 1-Hp infection is not associated
with impairment of insulin sensitivity, beta cell function
or deterioration in glucose metabolism; 2- Hp infection
seems to be metabolically neutral in terms of serum lipids
(total-cholesterol, LDL-cholesterol, HDL-cholesterol and
triglyceride) and serum transaminases in non-obese
young adult males.
Corresponding author:
Mehmet DURSUN

We also found that there is no relationship between
Hp infection and serum levels of total cholesterol, HDLcholesterol,
LDL-cholesterol,
VLDL-cholesterol,
triglyceride and transaminases (AST and ALT). Our study
groups consisted of healthy subjects apart from Hp
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